SRPT FY 2025 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.2B+15.6% YoY

Gross Profit

$1.3B59.9% margin

Operating Income

-$658M-29.9% margin

Net Income

-$713M-32.5% margin

EPS (Diluted)

$-7.13

Cash Flow

Operating Cash Flow

-$205M

Free Cash Flow

-$307M

Stock-Based Comp.

$123M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$2.2B

Stockholders' Equity

$1.1B

Cash & Equivalents

$801M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.2B	$1.9B	+15.6%
Gross Profit	$1.3B	$1.6B	-16.8%
Operating Income	-$658M	$218M	-401.6%
Net Income	-$713M	$235M	-403.3%